Despite slim chances that its vaccine will be ready by October, Pfizer has big incentives to hint that it might be.
from Health https://ift.tt/33fSDw9
September 30, 2020
Rose
Health, Health - The New York Times
No comments
Related Posts:
Budget Plan Offers Fix for Medicaid Coverage Gap, for NowThe $1.85 trillion social policy bill would provide free private health insurance for more than two million adults locked out of coverage, but only for four years. from NYT > Health https://ift.tt/3nHqYx6 … Read More
Chronic Kidney Disease May Be Over-Diagnosed in ElderlyMany men and women with “failing kidneys” may not have anything more than a normal age-related decline in kidney function. from NYT > Health https://ift.tt/2Y6et5J … Read More
Novavax Covid Vaccine Wins Authorization in IndonesiaAfter months of production delays, this is the first vaccine authorization for Novavax and its manufacturing partner, the Serum Institute of India. from NYT > Health https://ift.tt/3GF7B0s … Read More
Dr. Aaron T. Beck, Developer of Cognitive Therapy, Dies at 100It was an answer to Freudian analysis: a pragmatic, thought-monitoring approach to treating anxiety, depression and other mental disorders, and it changed psychiatry. from NYT > Health https://ift.tt/2ZKmcqg … Read More
Democrats’ Bill Would Cover Poor Uninsured Adults, Up to a PointThe $1.85 trillion social policy bill would provide free private health insurance for more than two million adults locked out of coverage, but only for four years. from NYT > Health https://ift.tt/3pXRmFO … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment